Maher Elhassan, Beckton Dickinson’s VP and general manager for the Middle East, North Africa, and Turkey (MENAT), comments on the company’s important role during the COVID-19 pandemic – including the provision of diagnostic tools and syringes for vaccination – and reveals why BD was the first medical technology company to be granted a 100 percent foreign-owned trading license in Saudi Arabia.
There is unprecedented demand for our innovation [in MENAT], which is why we look forward to continuing to offer our solutions and expertise to all relevant stakeholders; we understand that we can shape the future of healthcare for these communities
